BARD PERIPHERAL VASCULAR, INC.
Manufacturer adverse-event records for BARD PERIPHERAL VASCULAR, INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2003–2026 · heavy-book · elevated Death-code · balanced
Volume signature
BARD PERIPHERAL VASCULAR, INC. sits in the heavy MAUDE book
BARD PERIPHERAL VASCULAR, INC. accounts for 37,803 FDA MAUDE reports (#97 of 434, heavy-book tercile). Death-coded event_type share is 1.17% (elevated); Injury share 16.4% (balanced).
What the volume reading shows for BARD PERIPHERAL VASCULAR, INC.
The standout signal for BARD PERIPHERAL VASCULAR, INC. is filing volume: 37,803 adverse-event reports in FDA MAUDE (#97 of 434, heavy-book). Death-coded event_type share sits at 1.17% (elevated).
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair BARD PERIPHERAL VASCULAR, INC. with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 20 device types, led in this extract by Malfunction at 31,106 (82.3% of event_type total). Peak single-year volume reaches 7,566 reports across 24 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.